Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 19 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-0.84 Insider Own35.93% Shs Outstand259.85M Perf Week-0.67%
Market Cap766.56M Forward P/E- EPS next Y-0.80 Insider Trans0.09% Shs Float166.48M Perf Month44.61%
Income-126.86M PEG- EPS next Q-0.18 Inst Own27.54% Short Float12.02% Perf Quarter64.80%
Sales0.00M P/S- EPS this Y6.86% Inst Trans2.02% Short Ratio8.58 Perf Half Y65.73%
Book/sh1.91 P/B1.55 EPS next Y-2.98% ROA-30.29% Short Interest20.01M Perf Year8.86%
Cash/sh1.15 P/C2.58 EPS next 5Y- ROE-37.60% 52W Range1.51 - 3.33 Perf YTD38.50%
Dividend Est.- P/FCF- EPS past 5Y-69.36% ROI-37.40% 52W High-11.28% Beta1.19
Dividend TTM- Quick Ratio10.14 Sales past 5Y0.00% Gross Margin- 52W Low95.36% ATR (14)0.21
Dividend Ex-Date- Current Ratio10.14 EPS Y/Y TTM55.02% Oper. Margin0.00% RSI (14)62.61 Volatility7.98% 8.12%
Employees126 Debt/Eq0.21 Sales Y/Y TTM- Profit Margin- Recom1.33 Target Price5.38
Option/ShortYes / Yes LT Debt/Eq0.18 EPS Q/Q-4.28% Payout- Rel Volume0.69 Prev Close3.02
Sales Surprise- EPS Surprise-14.09% Sales Q/Q- EarningsMay 08 AMC Avg Volume2.33M Price2.95
SMA2017.06% SMA5025.14% SMA20038.55% Trades Volume1,611,246 Change-2.32%
Date Action Analyst Rating Change Price Target Change
Mar-11-24Initiated CapitalOne Overweight $8
Jan-05-24Downgrade BofA Securities Buy → Neutral $11 → $6
Oct-11-23Initiated H.C. Wainwright Buy $10
Mar-30-23Initiated Mizuho Buy $9
Feb-24-23Initiated Goldman Buy $10
Feb-03-23Upgrade Morgan Stanley Equal-Weight → Overweight $15
Jun-18-24 12:14PM
Jun-04-24 09:55AM
May-29-24 08:00AM
May-21-24 04:05PM
07:14AM Loading…
May-17-24 07:14AM
May-16-24 08:02PM
May-08-24 11:55PM
May-07-24 08:00AM
Apr-24-24 04:05PM
12:00PM Loading…
Apr-23-24 12:00PM
Apr-01-24 04:56PM
Mar-29-24 05:31AM
Mar-27-24 10:53PM
Feb-14-24 08:00AM
Feb-01-24 08:00AM
Jan-03-24 08:00AM
Dec-20-23 01:34PM
Dec-11-23 08:00AM
Nov-28-23 08:00AM
Nov-09-23 04:01PM
Nov-08-23 08:00AM
Oct-12-23 11:28AM
03:56PM Loading…
Oct-10-23 03:56PM
Sep-19-23 08:00AM
Sep-05-23 08:00AM
Aug-29-23 08:00AM
Aug-10-23 04:01PM
Jul-12-23 06:35AM
Jun-22-23 04:01PM
Jun-15-23 06:22AM
Jun-06-23 10:53AM
Jun-05-23 04:01PM
Jun-01-23 08:00AM
May-31-23 08:00AM
May-25-23 05:00PM
May-16-23 08:00AM
May-15-23 04:01PM
May-02-23 08:00AM
May-01-23 08:00AM
Apr-26-23 05:00PM
Apr-25-23 08:00AM
Apr-18-23 09:00AM
Apr-12-23 07:07AM
Apr-10-23 08:00AM
Mar-31-23 06:19AM
Mar-30-23 04:21AM
Mar-23-23 04:01PM
Mar-14-23 04:31PM
Feb-01-23 08:00AM
Jan-16-23 06:19AM
Jan-11-23 03:04PM
Jan-04-23 08:00AM
Dec-20-22 08:00AM
Dec-17-22 07:28AM
Dec-16-22 07:15AM
Dec-13-22 08:00AM
Dec-09-22 10:00AM
Nov-30-22 08:00AM
Nov-22-22 08:00AM
Nov-14-22 09:55AM
Nov-09-22 04:01PM
Oct-20-22 08:00AM
Oct-12-22 08:00AM
Sep-26-22 08:00AM
Sep-09-22 08:31AM
Sep-08-22 11:08AM
Sep-07-22 04:05PM
Aug-24-22 08:00AM
Aug-23-22 09:55AM
Aug-19-22 09:55AM
Aug-11-22 04:05PM
Aug-08-22 09:29AM
Aug-03-22 09:55AM
Jul-27-22 06:00PM
Jul-21-22 06:00PM
Jul-18-22 06:15PM
Jul-12-22 06:00PM
Jul-06-22 06:15PM
Jun-09-22 09:55AM
Jun-03-22 09:00AM
Jun-02-22 08:00AM
May-25-22 08:00AM
May-23-22 09:55AM
May-12-22 04:01PM
May-03-22 08:00AM
Apr-27-22 08:00AM
Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim on July 1, 2018 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Casdin Alexander W.DirectorMay 21 '24Buy2.2780,000181,920573,974May 22 06:57 PM
Lim Jonathan EChairman & CEODec 06 '23Buy1.72278,150478,41812,899,360Dec 06 07:41 PM
Start Valerie Denise HardingDirectorDec 06 '23Buy1.8510,00018,48020,000Dec 08 09:10 AM
Lim Jonathan EChairman & CEODec 05 '23Buy1.69721,8501,217,76112,899,360Dec 06 07:41 PM
Casdin Alexander W.DirectorDec 04 '23Buy1.6630,00049,785493,974Dec 04 06:23 PM
Lim Jonathan EChairman & CEOOct 05 '23Buy2.031,000,0002,026,00019,456,216Oct 10 08:00 AM